Search Results - "Davydova, Yu O"

Bone Marrow Multipotent Mesenchymal Stromal Cells in Patients with Diffuse Large B-Cell Lymphoma by Fastova, E. A., Magomedova, A. U., Petinati, N. A, Sats, N. V., Kapranov, N. M., Davydova, Yu. O., Drize, N. I., Kravchenko, S. K., Savchenko, V. G.

“…In diffuse large B-cell lymphoma, bone marrow involvement is rarely diagnosed. We compared the properties of bone marrow stromal progenitor cells and the…”
Get full text

Co-Culturing of Multipotent Mesenchymal Stromal Cells with Autological and Allogenic Lymphocytes by Kapranov, N. M., Davydova, Yu. O., Gal’tseva, I. V., Petinati, N. A., Bakshinskaitė, M. V., Drize, N. I., Kuz’mina, L. A., Parovichnikova, E. N., Savchenko, V. G.

“…We studied the effect of autologous and allogeneic lymphocytes on multipotent mesenchymal stromal cells in co-culture. It is shown that changes in multipotent…”
Get full text

Expression features of antigens involved in the formation of immunological synapse in splenic marginal zone lymphoma by Badmazhapova, D. S., Galtseva, I. V., Zvonkov, E. E., Davydova, Yu. O., Kapranov, M. M., Moiseeva, T. N., Kovrigina, A. M., Julhakyan, U. L., Danishyan, K. I., Sabirov, K. R., Parovichnikova, E. N., Savchenko, V. G.

“…Background . Splenic marginal zone lymphoma (SMZL) is an indolent non-Hodgkin’s B-cell lymphoma. It presents morphologically by mature lymphoid B-cells. They…”
Get full text

Changing the Properties of Multipotent Mesenchymal Stromal Cells by IFNγ Administration by Petinati, N. A., Kapranov, N. M., Bigil’deev, A. E., Popova, M. D., Davydova, Yu. O., Gal’tseva, I. V., Drize, N. I., Kuz’mina, L. A., Parovichnikova, E. N., Savchenko, V. G.

“…We studied changes in the population of human multipotent mesenchymal stromal cells activated by IFNγ. The cells were cultured under standard conditions; IFNγ…”
Get full text

Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment by Kuzmina, L A, Petinati, N A, Vasilieva, V A, Dovydenko, M V, Drokov, M Y, Davydova, Y O, Kapranov, N M, Sats, N V, Chabaeva, Y A, Kulikov, S M, Gaponova, T V, Drize, N I, Parovichnikova, E N, Savchenko, V G

“…Analysis of the effectiveness of the MSCs aministration as the second- or third-line therapy of acute GVHD (aGVHD) resistant to glucocorticosteroid treatment…”
Get full text

MULTICOLOR FLOW CYTOMETRY AS A DIAGNOSTIC TOOL IN MYELODYSPLASTIC SYNDROMES by Davydova, Yu. O., Galtseva, I. V., Kokhno, A. V., Parovichnikova, Е. N.

“…Myelodysplastic syndromes (MDS) are heterogeneous group of clonal hematological neoplasms characterized by cytopenias, sighs of dysplasia and high risk of…”
Get full text

Individual Differences of Multipotent Mesenchymal Stromal Cells Manifesting in during Interaction with Lymphocytes by Kapranov, N. M., Davydova, Yu. O., Gal’tseva, I. V., Petinati, N. A., Sats, N. V., Drize, N. I., Kuz’mina, L. A, Parovichnikova, E. N., Savchenko, V. G.

“…Analysis of changes in lymphocyte subpopulations during co-culturing with multipotent mesenchymal stromal cells (MSC) revealed two distinct MSC groups: one…”
Get full text

EXPRESSION FEATURES OF ANTIGENS INVOLVED IN THE FORMATION OF IMMUNOLOGICAL SYNAPSE IN CHRONIC LYMPHOCYTIC LEUKEMIA by Badmazhapova, D. S., Galtseva, I. V., Zvonkov, E. Е., Davydova, Yu. O., Kapranov, N. M., Chernova, N. G., Gabeeva, N. G., Moiseeva, T. N., Kovrigina, A. M., Dvirnyk, V. N., Dzhulakyan, U. L., Parovichnikova, E. N., Savchenko, V. G.

“…Background. Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disease that manifests by the accumulation of tumor monoclonal B-lymphocytes in the…”
Get full text

Absolute numbers of peripheral blood CD34+ hematopoietic stem cells prior to a leukapheresis procedure as a parameter predicting the efficiency of stem cell collection by Galtseva, I V, Davydova, Yu O, Gaponova, T V, Kapranov, N M, Kuzmina, L A, Troitskaya, V V, Gribanova, E O, Kravchenko, S K, Mangasarova, Ya K, Zvonkov, E E, Parovichnikova, E N, Mendeleeva, L P, Savchenko, V G

“…To identify a parameter predicting a collection of at least 2·106 CD34+ hematopoietic stem cells (HSC)/kg body weight per leukapheresis (LA) procedure. The…”
Get full text

Dynamics of T cell subpopulation in patients with aplastic anemia during immunosuppressive therapy by Abramova, A. V., Mikhailova, E. A., Galtseva, I. V., Fidarova, Z. T., Luchkin, A. V., Kapranov, N. M., Davydova, Yu. O., Kulikov, S. M., Troitskaya, V. V., Parovichnikova, E. N.

“…Background. Aplastic anemia (AA) is a non-tumor and rare disease of the blood system, characterized by deep pancytopenia due to the development of bone marrow…”
Get full text

Influence of baseline telomere length on the results of immunosuppressive therapy in aplastic anemia patients by Luchkin, A. V., Mikhailova, E. A., Galtseva, I. V., Fidarova, Z. T., Abramova, A. V., Davydova, Yu. O., Kapranov, N. M., Nikiforova, K. A., Tsoy, Yu. A., Kulikov, S. M., Parovichnikova, E. N.

“…Background . Acquired aplastic anemia (AA) is a non-tumor disease of the blood system and the pathogenesis is based on immune dysregulation directed against…”
Get full text

Immunophenotyping of blood and bone marrow cells as a way to search for differentiation syndrome risk factors in acute promyelocytic leukemia by Semenova, A. A., Galtseva, I. V., Troitskaya, V. V., Kapranov, N. M., Davydova, Yu. O., Nikiforova, K. A., Loseva, A. G., Ermolaev, A. A., Surimova, V. A., Kulikov, S. M., Parovichnikova, E. N.

“…Background. Differentiation syndrome (DS) is a potentially fatal complication of therapy for acute promyelocytic leukemia (APL) with an incidence of up to 48…”
Get full text

Telomere length of various blood and bone marrow cells in patients with aplastic anemia by Luchkin, A. V., Mikhailova, E. A., Galtseva, I. V., Fidarova, Z. T., Abramova, A. V., Davydova, Yu. O., Kapranov, N. M., Nikiforova, K. A., Kulikov, S. M., Parovichnikova, E. N.

“…   Background.  Aplastic anemia proceeds with bone marrow failure and is associated with immunological suppression of normal blood stem cells’ proliferation,…”
Get full text

Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial by Aleshina, O. A., Galtseva, I. V., Kotova, E. S., Isinova, G. I., Obukhova, T. N., Dvirnik, V. N., Sudarikov, A. B., Grishunina, M. E., Samoilova, O. S., Kaplanov, K. D., Lapin, V. A., Bondarenko, S. N., Fokina, E. S., Minaeva, N. V., Konstantinova, T. S., Sveshnikova, Yu. V., Zinina, E. E., Antipova, A. S., Baranova, O. Yu, Borisenkova, E. A., Davydova, Yu. O., Kapranov, N. M., Kulikov, S. M., Chabaeva, Yu. A., Troitskaya, V. V., Parovichnikova, E. N.

“…Background. The effectiveness of therapy for acute T-lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) has significantly improved over the…”
Get full text

Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation by Mikhaltsova, E. D., Popova, N. N., Drokov, M. Yu, Kapranov, N. M., Davydova, Yu. O., Vasilieva, V. A., Dubnyak, D. S., Maslikova, U. V., Galtseva, I. V., Kuzmina, L. A., Parovichnikova, E. N., Savchenko, V. G.

“…The graft-versus-host disease (GVHD) is among the most common complications after hematopoietic stem cell transplantation (allo-HSCT). The main tools for GVHD…”
Get full text

Comparison of polymerase chain reaction and flow cytometry for measuring telomere length of human leukocytes by Galtseva, I V, Filipenko, M L, Davydova, Yu O, Luchkin, A V, Kapranov, N M, Kondratieva, Yu A, Subbotin, S V, Khrapov, E A, Nikiforova, K A, Fidarova, Z T, Gaponova, T V, Mendeleeva, L P, Mikhailova, E A, Parovichnikova, E N, Savchenko, V G

“…Telomere length can be measured by polymerase chain reaction (PCR), allowing to obtain the absolute length of telomeres (ALT) in base pair, and by flow…”
Get more information

Subpopulations of mobilized hematopoietic stem cells in patients with hematological malignances and donors: expression of CD38, HLA-DR and CD143 by Kanaeva, M. L., Galtseva, I. V., Parovichnikova, E. N., Davydova, Yu. O., Gaponova, T. V., Gribanova, E. O., Balzhanova, Ya. V., Kuzmina, L. A., Troitskaya, V. V., Kravchenko, S. K., Zvonkov, E. E., Mendeleeva, L. P., Savchenko, V. G.

“…The study objective is to investigate the features of subpopulational composition of mobilized hematopoietic stem cells in peripheral blood (PB) and leukocyte…”
Get full text

Study of myelodysplastic features in patients with myelodysplastic syndromes by multicolor flow cytometry by Davydova, O. Yu, Galtseva, I. V., Parovichnikova, E. N., Kokhno, A. V., Kapranov, N. M., Troitskaya, V. V., Mikhailova, E. A., Fidarova, Z. T., Moiseeva, T. N., Kuzmina, L. A., Lukina, E. A., Obukhova, T. N., Grebenyuk, L. A., Kovrigina, A. M., Dvirnyk, V. N., Savchenko, V. G.

“…Background .  Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal diseases of the hematopoiesis system characterized by dismyelopoiesis and…”
Get full text

Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual disease by Solovyev, M V, Mendeleeva, L P, Pokrovskaya, O S, Nareyko, M V, Firsova, M V, Galtseva, I V, Davydova, Yu O, Kapranov, N M, Kuzmina, L A, Gemdzhian, E G, Savchenko, V G

“…To determine the efficiency of maintenance therapy with bortezomib in patients with multiple myeloma (MM) who have achieved complete remission (CR) after…”
Get full text

ІЄРАРХІЧНА СИСТЕМА СТРАТЕΓІЙ ІННОВАЦІЙНОΓО УПРАВЛІННЯ РОЗВИТКОМ ПІДПРИЄМСТВ ΓОТЕЛЬНО-РЕСТОРАННОΓО ΓОСПОДАРСТВА НА АКТИВНО-АДАПТИВНИХ ЗАСАДАХ by Prokhorova, V V, Davydova, O Yu

“…Мета статті – формування ієрархічної системи стратегій інноваційного управління розвитком підприємств готельно-ресторанного господарства на активно-адаптивних…”
Get full text